GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Net Issuance of Debt

TrivarX (TrivarX) Net Issuance of Debt : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. TrivarX's net issuance of debt for the six months ended in Dec. 2023 was $0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


TrivarX Net Issuance of Debt Historical Data

The historical data trend for TrivarX's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Net Issuance of Debt Chart

TrivarX Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.63 - - - -

TrivarX Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 - -0.03 - -

TrivarX Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of TrivarX's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX (TrivarX) Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.

TrivarX (TrivarX) Headlines

From GuruFocus

Receipt of $3,146,835 R&D Tax Incentive Refund

By Marketwired Marketwired 10-15-2018

Medibio Launches Global Corporate Mental Health Product

By Marketwired Marketwired 05-01-2018

Medibio Receives TGA Approval

By Marketwired Marketwired 06-19-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018

Medibio Announces Next Tranche of Corporate Health Contracts

By Marketwired Marketwired 05-10-2018

Medibio Announces Executive Leadership Changes

By Marketwired Marketwired 09-21-2018